Jump to content

Wikipedia:Choosing Wisely/Society of Gynecologic Oncology

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Dexbot (talk | contribs) at 18:45, 3 December 2015 (Bot: Deprecating Template:Cite pmid and some minor fixes). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Choosing Wisely is a health campaign which seeks to share health information with patients and health care providers.

This project shares information from the Society of Gynecologic Oncology on Wikipedia.

Articles of interest

[edit]
Articles relating to Society of Gynecologic Oncology content
article traffic in April 2014 sources cited change summary
Society of Gynecologic Oncology 193
Ovarian cancer 35919 1 Women who are not at above average risk for ovarian cancer should not be routinely screened for it
Pap test 44305 2 Women with a history of endometrial cancer should discontinue routine pap tests
Colposcopy 14419 3 should not be performed for persons treated for cervical cancer if their pap tests show low-grade squamous intraepithelial lesion
Vaginal cancer 2669 4 Women with vaginal cancer should not have routine surveillance imaging to monitor the cancer unless new symptoms appear
Endometrial cancer 19417 4 Women with endometrial cancer should not have routine surveillance imaging to monitor the cancer unless new symptoms appear
Vulvar cancer 4992 4 Women with vulvar cancer should not have routine surveillance imaging to monitor the cancer unless new symptoms appear
Ovarian cancer 35919 4 Women with ovarian cancer should not have routine surveillance imaging to monitor the cancer unless new symptoms appear
Ovarian cancer 35919 5 Women with advanced ovarian cancer or a relapse should get palliative care immediately
  • *An arbitrary month has been chosen to present a count of pageviews. This month is neither the busiest nor slowest month, and this number seems typical for most articles in most months. Through the link anyone may check traffic in other months.

Recent changes

[edit]

Review changes to all of the articles in the above table by visiting this watchlist.

References

[edit]

Society of Gynecologic Oncology (February 2014), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, Society of Gynecologic Oncology, retrieved 19 February 2013, which cites

    • Moyer, V. A.; U.S. Preventive Services Task Force (2012). "Screening for Ovarian Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement". Annals of Internal Medicine. 157 (12): 900–4. doi:10.7326/0003-4819-157-11-201212040-00539. PMID 22964825.
    • Buys, S. S. (2011). "Effect of Screening on Ovarian Cancer Mortality". JAMA. 305 (22): 2295. doi:10.1001/jama.2011.766.
    • American College of Obstetricians; Gynecologists Committee on Gynecologic Practice (2011). "Committee Opinion No. 477: The Role of the Obstetrician–Gynecologist in the Early Detection of Epithelial Ovarian Cancer". Obstetrics & Gynecology. 117 (3): 742–746. doi:10.1097/AOG.0b013e31821477db. PMID 21343791.
    • Salani, R.; Backes, F. J.; Fung Kee Fung, M.; Holschneider, C. H.; Parker, L. P.; Bristow, R. E.; Goff, B. A. (2011). "Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations". American Journal of Obstetrics and Gynecology. 204 (6): 466–78. doi:10.1016/j.ajog.2011.03.008. PMID 21752752.
    • Salani, R.; Nagel, C. I.; Drennen, E.; Bristow, R. E. (2011). "Recurrence patterns and surveillance for patients with early stage endometrial cancer". Gynecologic Oncology. 123 (2): 205–7. doi:10.1016/j.ygyno.2011.07.014. PMID 21820709.
    • Bristow, R. E.; Purinton, S. C.; Santillan, A; Diaz-Montes, T. P.; Gardner, G. J.; Giuntoli Rl, 2nd (2006). "Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance". Gynecologic Oncology. 103 (2): 709–13. doi:10.1016/j.ygyno.2006.05.013. PMID 16797686.{{cite journal}}: CS1 maint: numeric names: authors list (link)
    • Rimel, B. J.; Ferda, A.; Erwin, J.; Dewdney, S. B.; Seamon, L.; Gao, F.; Desimone, C.; Cotney, K. K.; Huh, W.; Massad, L. S. (2011). "Cervicovaginal Cytology in the Detection of Recurrence After Cervical Cancer Treatment". Obstetrics & Gynecology. 118 (3): 548. doi:10.1097/AOG.0b013e3182271fdd.
    • Tergas, A. I.; Havrilesky, L. J.; Fader, A. N.; Guntupalli, S. R.; Huh, W. K.; Massad, L. S.; Rimel, B. J. (2013). "Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer". Gynecologic Oncology. 130 (3): 421. doi:10.1016/j.ygyno.2013.05.037.
    • Sartori, E; Pasinetti, B; Carrara, L; Gambino, A; Odicino, F; Pecorelli, S (2007). "Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients". Gynecologic Oncology. 107 (1 Suppl 1): S241-7. doi:10.1016/j.ygyno.2007.07.025. PMID 17826824.
    • Berchuck, A; Anspach, C; Evans, A. C.; Soper, J. T.; Rodriguez, G. C.; Dodge, R; Robboy, S; Clarke-Pearson, D. L. (1995). "Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma". Gynecologic Oncology. 59 (1): 20–4. doi:10.1006/gyno.1995.1262. PMID 7557610.
    • Bhosale, P.; Peungjesada, S.; Wei, W.; Levenback, C. F.; Schmeler, K.; Rohren, E.; MacApinlac, H. A.; Iyer, R. B. (2010). "Clinical Utility of Positron Emission Tomography/Computed Tomography in the Evaluation of Suspected Recurrent Ovarian Cancer in the Setting of Normal CA-125 Levels". International Journal of Gynecological Cancer. 20 (6): 936–44. doi:10.1111/IGC.0b013e3181e82a7f. PMID 20683399.
    • Havrilesky, L. J.; Wong, T. Z.; Secord, A. A.; Berchuck, A; Clarke-Pearson, D. L.; Jones, E. L. (2003). "The role of PET scanning in the detection of recurrent cervical cancer". Gynecologic oncology. 90 (1): 186–90. doi:10.1016/s0090-8258(03)00256-7. PMID 12821362.
    • Rimel, B. J.; Ferda, A.; Erwin, J.; Dewdney, S. B.; Seamon, L.; Gao, F.; Desimone, C.; Cotney, K. K.; Huh, W.; Massad, L. S. (2011). "Cervicovaginal Cytology in the Detection of Recurrence After Cervical Cancer Treatment". Obstetrics & Gynecology. 118 (3): 548. doi:10.1097/AOG.0b013e3182271fdd.
    • Smith, T. J.; Temin, S.; Alesi, E. R.; Abernethy, A. P.; Balboni, T. A.; Basch, E. M.; Ferrell, B. R.; Loscalzo, M.; Meier, D. E.; Paice, J. A.; Peppercorn, J. M.; Somerfield, M.; Stovall, E.; von Roenn, J. H. (2012). "American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care into Standard Oncology Care". Journal of Clinical Oncology. 30 (8): 880–7. doi:10.1200/JCO.2011.38.5161. PMID 22312101.
    • Rezk, Y.; Timmins, P. F.; Smith, H. S. (2010). "Review Article: Palliative Care in Gynecologic Oncology". American Journal of Hospice and Palliative Medicine. 28 (5): 356–74. doi:10.1177/1049909110392204. PMID 21187291.
    • Lewin, S. N.; Buttin, B. M.; Powell, M. A.; Gibb, R. K.; Rader, J. S.; Mutch, D. G.; Herzog, T. J. (2005). "Resource utilization for ovarian cancer patients at the end of life: How much is too much?". Gynecologic Oncology. 99 (2): 261–6. doi:10.1016/j.ygyno.2005.07.102. PMID 16140364.
    • Delgado-Guay, M. O.; Parsons, H. A.; Li, Z.; Palmer, L. J.; Bruera, E. (2009). "Symptom distress, interventions, and outcomes of intensive care unit cancer patients referred to a palliative care consult team". Cancer. 115 (2): 437–445. doi:10.1002/cncr.24017. PMID 19107768.
    • Temel, J. S.; Greer, J. A.; Muzikansky, A.; Gallagher, E. R.; Admane, S.; Jackson, V. A.; Dahlin, C. M.; Blinderman, C. D.; Jacobsen, J.; Pirl, W. F.; Billings, J. A.; Lynch, T. J. (2010). "Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer". New England Journal of Medicine. 363 (8): 733–742. doi:10.1056/NEJMoa1000678. PMID 20818875.
    • Elsayem, A.; Swint, K.; Fisch, M. J.; Palmer, J. L.; Reddy, S.; Walker, P.; Zhukovsky, D.; Knight, P.; Bruera, E. (2004). "Palliative Care Inpatient Service in a Comprehensive Cancer Center: Clinical and Financial Outcomes". Journal of Clinical Oncology. 22 (10): 2008–2014. doi:10.1200/JCO.2004.11.003. PMID 15143094.
    • Fauci, J.; Schneider, K.; Walters, C.; Boone, J.; Whitworth, J.; Killian, E.; Straughn, J. M. (2012). "The utilization of palliative care in gynecologic oncology patients near the end of life". Gynecologic Oncology. 127: 175. doi:10.1016/j.ygyno.2012.06.025.
    • Albanese, T. H.; Radwany, S. M.; Mason, H.; Gayomali, C.; Dieter, K. (2013). "Assessing the Financial Impact of an Inpatient Acute Palliative Care Unit in a Tertiary Care Teaching Hospital". Journal of Palliative Medicine. 16 (3): 289. doi:10.1089/jpm.2012.0243.
    • Quill, T. E.; Abernethy, A. P. (2013). "Generalist plus Specialist Palliative Care — Creating a More Sustainable Model". New England Journal of Medicine. 368 (13): 1173. doi:10.1056/NEJMp1215620.
[edit]